Results 201 to 210 of about 14,439 (224)
Some of the next articles are maybe not open access.

Biosimilars in Belgium: A Proposal for a More Competitive Market

Acta Clinica Belgica, 2021
Isabelle Huys   +2 more
exaly  

Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars

Drug Design, Development and Therapy, 2022
Sarfaraz Khan Niazi
exaly  

Nocebo Effect and Biosimilars in Inflammatory Bowel Diseases: What’s New and What’s Next?

Expert Opinion on Biological Therapy, 2021
Silvio Danese   +2 more
exaly  

Analytical Tools for Characterizing Biopharmaceuticals and the Implications for Biosimilars

Nature Reviews Drug Discovery, 2012
John R. Engen   +2 more
exaly  

Home - About - Disclaimer - Privacy